Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-05-08 @ 9:13 AM
Study NCT ID:
NCT00171769
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atrial Fibrillation Feasibility Certoparin Trial - AFFECT
Sponsor:
Novartis
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Persistent Nonvalvular Atrial Fibrillation | View |
Keywords: